These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 359394)

  • 61. Markers of beta cell function in type 1 diabetes mellitus.
    Vendrame F; Zappaterreno A; Dotta F
    Minerva Med; 2004 Apr; 95(2):79-84. PubMed ID: 15272242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. B-cell secretion in non-diabetics and insulin-dependent diabetics.
    Heding LG; Ludvigsson J; Kasperska-Czyzykowa T
    Acta Med Scand Suppl; 1981; 656():5-9. PubMed ID: 7046350
    [No Abstract]   [Full Text] [Related]  

  • 63. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
    Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
    Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Residual B-cell function in insulin-dependent (type I) diabetics with and without retinopathy.
    Sberna P; Valentini U; Cimino A; Sabatti MC; Rotondi A; Crisetig M; Spandrio S
    Acta Diabetol Lat; 1986; 23(4):339-44. PubMed ID: 3551428
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
    Christiansen E; Tibell A; Groth CG; Rasmussen K; Pedersen O; Burcharth F; Christensen NJ; Vølund A; Madsbad S
    Transplant Proc; 1994 Apr; 26(2):467-8. PubMed ID: 8171508
    [No Abstract]   [Full Text] [Related]  

  • 66. Perinatal islet function in gestational diabetes: assessment by cord plasma C-peptide and amniotic fluid insulin.
    Ogata ES; Freinkel N; Metzger BE; Phelps RL; Depp R; Boehm JJ; Dooley SL
    Diabetes Care; 1980; 3(3):425-9. PubMed ID: 6993160
    [No Abstract]   [Full Text] [Related]  

  • 67. Residual beta-cell function in type II diabetes and evaluation of the hepatic insulin extraction.
    Toledo e Souza IT; Wajchenberg BL; Prestes Cesar F; Almeida Neto JS
    Horm Metab Res; 1983 Dec; 15(12):575-80. PubMed ID: 6363239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of residual beta-cell function on the development of diabetic retinopathy.
    Madsbad S; Lauritzen E; Faber OK; Binder C
    Diabet Med; 1986 Jan; 3(1):42-5. PubMed ID: 2951134
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasma and urinary C-peptide in the classification of adult diabetics.
    Koskinen P; Viikari J; Irjala K; Kaihola HL; Seppälä P
    Scand J Clin Lab Invest; 1986 Nov; 46(7):655-63. PubMed ID: 3538365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.
    Canivet B; Harter M; Viot G; Balarac N; Krebs BP
    J Endocrinol Invest; 1980; 3(2):107-11. PubMed ID: 6993546
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Complete loss of insulin secretion capacity in type 1A diabetes patients during long-term follow up.
    Uno S; Imagawa A; Kozawa J; Fukui K; Iwahashi H; Shimomura I
    J Diabetes Investig; 2018 Jul; 9(4):806-812. PubMed ID: 29034607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prednisone administration in recent onset type I diabetes.
    Secchi A; Pastore MR; Sergi A; Pontiroli AE; Pozza G
    J Autoimmun; 1990 Oct; 3(5):593-600. PubMed ID: 2252527
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Remission phase, endogenous insulin secretion and metabolic control in diabetic children.
    Knip M; Puukka R; Käär ML; Akerblom HK
    Acta Diabetol Lat; 1982; 19(3):243-51. PubMed ID: 6756005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.
    Mirouze J; Selam JL; Pham TC; Mendoza E; Orsetti A
    Diabetologia; 1978 Apr; 14(4):223-7. PubMed ID: 640299
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Honeymoon period in insulin-dependent diabetes mellitus.
    Heinze E; Thon A
    Pediatrician; 1983-1985; 12(4):208-12. PubMed ID: 6400451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The remission stage in juvenile diabetes].
    Buysschaert M; Ketelslegers JM; Van Halle B; Lambert AE
    Acta Clin Belg; 1980; 35(5):293-9. PubMed ID: 7013394
    [No Abstract]   [Full Text] [Related]  

  • 77. Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics.
    Giordano C; Galluzzo A; Pantò F; Caruso C; Bompiani G
    Acta Diabetol Lat; 1987; 24(4):317-23. PubMed ID: 3326380
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Basal C peptide levels in response to intravenous tolbutamide in the detection of incorrect insulin therapy (or prolonged misuse)].
    Wemeau JL; Fourlinnie JC; Beuscart R; Vaast D; Romon M; Vie MC; Fossati P
    Rev Med Interne; 1983 Mar; 4(1):11-7. PubMed ID: 6346452
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temporary partial remission in type I diabetes of juvenile onset.
    Weber B; Hasala M
    Acta Paediatr Jpn; 1987 Jun; 29(3):393-400. PubMed ID: 3144868
    [No Abstract]   [Full Text] [Related]  

  • 80. C-peptide and residual β-cell function in pediatric diabetes - state of the art.
    Jamiołkowska-Sztabkowska M; Głowińska-Olszewska B; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2021; 27(2):123-133. PubMed ID: 34514768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.